Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1983-9-23
|
| pubmed:abstractText |
This work reports a multicenter study of antibacterial activity of azthreonam, a new antibacterial agent of the monobactam group, on Gram negative rods. Enterobacteriaceae are very sensitive to azthreonam (modal MIC: 0,06 micrograms/ml); some strains have higher MIC greater than or equal to 8 micrograms/ml, particularly among Enterobacter, Serratia and Citrobacter. Azthreonam has a good activity on Pseudomonas aeruginosa: 90% of the strains are inhibited by 8 micrograms/ml or less. Acinetobacter are less sensitive with a modal MIC of 32 micrograms/ml. Haemophilus are inhibited by low concentrations, 0,06 to 0,12 micrograms/ml usually.
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0369-8114
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
31
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
488-91
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:year |
1983
|
| pubmed:articleTitle |
[In vitro activity of azthreonam on hospital Gram-negative bacilli. Results of a multicenter study].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|